Congratulations to Dr. Pramod Regmi in the Faculty of Health & Social Sciences (FHSS) who is the lead author of the paper “Hormone use among Nepali transgender women: A qualitative study” which has just been accepted for publication in BMJ Open (Impact Factor 2.376). The paper highlights that there is a dearth of information on transgender individuals in Nepal, particularly studies exploring their use of hormone therapies. This qualitative study therefore explored: (a) how hormones are used; (b) types of hormones used; and (c) side-effects experienced by transgender women after hormone use. This is the first study in Nepal of its kind addressing this important public health issue.
The paper was co-authored by Sanjeev Neupane, Sujan Marahatta and Edwin van Teijlingen. Prof. Sujan Marahatta is based at Manmohan Memorial Institute of Health Sciences in Nepal. Bournemouth University has a long-standing collaboration with Manmohan Memorial Institute of Health Sciences. Whilst Mr. Sanjeev Raj Neupane is based at the charity Save the Children in Kathmandu.
Reference:
- Regmi, P., Neupane, S., van Teijlingen, E., Marahatta, S. Hormone use in the male-to-female transgender population in Nepal: A qualitative study, BMJ Open (accepted).











































Congratulation on newly published systematic review
Equitable Partnerships in Global Health Research
New Nepal-based paper published last week
Congratulation to HEMS colleagues on their new book!
Book edited by BU academics published
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease